Humacyte will consider individual patient expanded-access requests case by case. This policy will be reviewed regularly as product development continues, and any changes to the policy will be updated in this location. The following is additional information regarding Humacyte’s expanded access policy in accordance with the 21st Century Cures Act:
If you have any questions regarding Humacyte’s expanded access policy or are interested in participating in a clinical trial, please contact Humacyte at 919-313-9633 x171, or by email at firstname.lastname@example.org.
Our individual patient Expanded Access policy is located at:
Humacyte may revise this expanded access policy at any time. Additionally, the posting of this policy by Humacyte shall not serve as a guarantee of access to any specific investigational product by any individual patient.